Holman RR - Search Results

1

Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL.

Standl E, Stevens SR, Lokhnygina Y, Bethel MA, Buse JB, Gustavson SM, Maggioni AP, Mentz RJ, Hernandez AF, Holman RR; EXSCEL Study Group. Standl E, et al. Among authors: holman rr. Diabetes Care. 2020 Mar;43(3):643-652. doi: 10.2337/dc19-1079. Epub 2019 Dec 27. Diabetes Care. 2020. PMID: 31882409 Clinical Trial.

2

Insulin use in NIDDM. Rationale based on pathophysiology of disease.

Turner RC, Holman RR. Turner RC, et al. Among authors: holman rr. Diabetes Care. 1990 Sep;13(9):1011-20. doi: 10.2337/diacare.13.9.1011. Diabetes Care. 1990. PMID: 2226108 Review.

3

U.K. Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM.

Davis TM, Stratton IM, Fox CJ, Holman RR, Turner RC. Davis TM, et al. Among authors: holman rr. Diabetes Care. 1997 Sep;20(9):1435-41. doi: 10.2337/diacare.20.9.1435. Diabetes Care. 1997. PMID: 9283793

4

Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.

Rachman J, Payne MJ, Levy JC, Barrow BA, Holman RR, Turner RC. Rachman J, et al. Among authors: holman rr. Diabetes Care. 1998 May;21(5):810-6. doi: 10.2337/diacare.21.5.810. Diabetes Care. 1998. PMID: 9589246 Clinical Trial.

5

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44).

Holman RR, Cull CA, Turner RC. Holman RR, et al. Diabetes Care. 1999 Jun;22(6):960-4. doi: 10.2337/diacare.22.6.960. Diabetes Care. 1999. PMID: 10372249 Clinical Trial.

6

UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes.

Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR. Adler AI, et al. Among authors: holman rr. Diabetes Care. 2002 May;25(5):894-9. doi: 10.2337/diacare.25.5.894. Diabetes Care. 2002. PMID: 11978687

7

Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?: U.K. prospective diabetes study 61.

Colagiuri S, Cull CA, Holman RR; UKPDS Group. Colagiuri S, et al. Among authors: holman rr. Diabetes Care. 2002 Aug;25(8):1410-7. doi: 10.2337/diacare.25.8.1410. Diabetes Care. 2002. PMID: 12145243

8

A standardized triglyceride and carbohydrate challenge: the oral triglyceride tolerance test.

Mohanlal N, Holman RR. Mohanlal N, et al. Among authors: holman rr. Diabetes Care. 2004 Jan;27(1):89-94. doi: 10.2337/diacare.27.1.89. Diabetes Care. 2004. PMID: 14693972

9

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.

Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR. Stevens RJ, et al. Among authors: holman rr. Diabetes Care. 2004 Jan;27(1):201-7. doi: 10.2337/diacare.27.1.201. Diabetes Care. 2004. PMID: 14693990

10

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).

Adler AI, Levy JC, Matthews DR, Stratton IM, Hines G, Holman RR. Adler AI, et al. Among authors: holman rr. Diabet Med. 2005 Mar;22(3):306-11. doi: 10.1111/j.1464-5491.2004.01418.x. Diabet Med. 2005. PMID: 15717879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

368 results

Search Page

Filters